The success of drugs like Keytruda is reshaping the pharmaceutical industry's competitive landscape. Merck & Co., Keytruda's manufacturer, has seen its overall revenue increase to 60.1 billion in 2023, driven largely by its oncology franchise. The company's commitment to innovation is evident in ...
Keytruda is not only Merck & Co.’s top product but also one of the best-selling drugs worldwide, generating some 25 billion U.S. dollars in revenue during 2023. The cancer drug with the generic name pembrolizumab increased its revenues for around four billion U.S. dollars compared to 202...
The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. ...
The top 20 drugs by worldwide sales in 2023 ByZoey Becker,Angus Liu,Kevin Dunleavy,Fraiser Kansteiner,Eric SagonowskyMay 28, 2024 03:00pm drug launchKeytrudaComirnatyHumira It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 以往年度的回顾文章参见 Nat Rev Drug Discov|2022年销售额排名Top10的制药公司和药品 Nat Rev Drug Discov|2021年制药公司和药物的销售额Top10 ...
Learning essential information about the top 300 prescription drugs doesn’t have to be tedious. With Prescription Drug Cards: Top 300, you’ll get a comprehensiv…
With indications for both type 2 diabetes and weight loss, Novo Nordisk achieved a remarkable sales figure of DKK 100.222 billion (approximately USD 14.232 billion) in the first three quarters of 2023, marking an impressive year-on-year growth of 86% despite limited production capacity. Novo Nord...
基因疗法的价格高不仅是因为该疗法研发制备成本高昂,同时也因为其具有一次性治愈的潜力。罕见病药物定价高是因为罕见病患者少、市场小,开发成本高,企业要想获得与常用药物相同的收益,就势必要提高单价。 参考资料:www.fiercepharma.com/special-reports/priciest-drugs-2023...
1.www.fiercepharma.com/special-reports/priciest-drugs-2023 2.药融云数据库 <END> 要解锁更多企业药品研发信息吗?查询药融云数据库(vip.pharnexcloud.com/?zmt-mhwz)掌握药品各国上市情况、药品批文信息、销售情况与各维度分析、市场竞争格局、一致性评价情况、集采中标情况、药企申报审批信息、最新动态与前景等...
——Drug.com上给出的不同规格的Revlimid口服胶囊(2.5~25 mg)的价格均为877.72美元/粒。每个周期(28天)需要16.9万人民币的治疗费用。国内目前每月治疗费用约为1.8万。虽然与Keytruda同是抗癌药,但是Keytruda没法覆盖Revlimid治疗的这三种疾病。Revlimid的全球累计销售额高于Keytruda 300亿元。